المؤلفون: Busker, S, Jones, AW, Hahn, RG, Taubert, M, Klotz, U, Schwab, M, Fuhr, U

المصدر: Journal of clinical pharmacology. 63(6):681-694

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:152323443

المؤلفون: Chen, Z., Chen, C., Taubert, M., Mayersohn, M., Fuhr, U.

المساهمون: College of Pharmacy, University of Arizona

المصدر: European Journal of Clinical Pharmacology

مصطلحات موضوعية: Creatinine, Creatinine generation rate, Population pharmacokinetic model, Volume of distribution

Relation: Chen, Z., Chen, C., Taubert, M., Mayersohn, M., & Fuhr, U. (2022). A population pharmacokinetic model for creatinine with and without ingestion of a cooked meat meal. European Journal of Clinical Pharmacology.; http://hdl.handle.net/10150/667055; European Journal of Clinical Pharmacology

الاتاحة: http://hdl.handle.net/10150/667055
https://doi.org/10.1007/s00228-022-03398-9

المؤلفون: Stemkens, R., Jager, V.d., Dawson, R., Diacon, A.H., Narunsky, K., Padayachee, S.D., Boeree, M.J., Beek, S.W. van, Colbers, A.P., Coenen, M.J.H., Svensson, E.M., Fuhr, U., Phillips, P.P., Brake, L.H.M. te, Aarnoutse, R.E.

المصدر: Antimicrobial Agents and Chemotherapy, 67, 10, pp. e0068323

مصطلحات الفهرس: All institutes and research themes of the Radboud University Medical Center, Radboudumc 4: lnfectious Diseases and Global Health Clinical Pharmacy, Radboudumc 4: lnfectious Diseases and Global Health Pulmonary Diseases, Article / Letter to editor

URL: https://repository.ubn.ru.nl//bitstream/handle/2066/300036/300036.pdf
https://repository.ubn.ru.nl/handle/2066/300036

المؤلفون: Karas Kuželički, N. (Nataša), Prodan Žitnik, I. (Irena), Gurwitz, D. (David), Llerena, A. (Adrián), Cascorbi, I. (Ingolf), Siest, S. (Sofia), Simmaco, M. (Maurizio), Ansari, M. (Marc), Pazzagli, M. (Mario), Di Resta, C. (Chiara), Brandslund, I. (Ivan), Schwab, M. (Matthias), Vermeersch, P. (Paul), Lunshof, J.E. (Jeantine E.), Dedoussis, G.V. (George), Flordellis, C.S. (Christodoulos S.), Fuhr, U. (Uwe), Stingl, J. (Julia), Schaik, R.H.N. (Ron) van, Manolopoulos, V.G. (Vangelis), Marc, J. (Janja)

المصدر: Pharmacogenomics vol. 20 no. 9, pp. 643-657

مصطلحات موضوعية: education, global survey, medicine, pharmacogenomics, pharmacy, recommendations

وصف الملف: application/pdf

Relation: http://repub.eur.nl/pub/117637; urn:hdl:1765/117637

الاتاحة: http://repub.eur.nl/pub/117637
https://doi.org/10.2217/pgs-2019-0009

المؤلفون: Dahlinger, D, Frechen, S, Aslan, S, Fuhr, U

المصدر: 17. Jahreskongress für Klinische Pharmakologie; 20151001-20151002; Köln; DOC15vklipha08 /20150924/

مصطلحات موضوعية: ddc: 610

Relation: Die überaktive Blase (ÜAB), AWMF, Register Nr. 015/007 Klasse: S2k, Stand Juni 2010. http://www.awmf.org/uploads/tx_szleitlinien/015-007l_S2k_Ueberaktive_Blase_Add_2014-07.pdf (assessed March 2015); Cheng Y, Prusoff WH. Relationship between the inhibition constant (Ki) and the concentration of an inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol. 1973;22:3099-108. DOI:10.1016/0006-2952(73)90196-2; Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001 Jun;87(9):760-6. DOI:10.1046/j.1464-410x.2001.02228.x; Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003 May;20(6):327-36.; http://dx.doi.org/10.3205/15vklipha08; http://nbn-resolving.de/urn:nbn:de:0183-15vklipha087; http://www.egms.de/en/meetings/vklipha2015/15vklipha08.shtml

الاتاحة: https://doi.org/10.3205/15vklipha08
http://nbn-resolving.de/urn:nbn:de:0183-15vklipha087
http://www.egms.de/en/meetings/vklipha2015/15vklipha08.shtml

المؤلفون: Taubert, M, Schäffner, E, Ebert, N, van der Giet, M, Martus, P, Jakob, O, Fuhr, U

المصدر: 17. Jahreskongress für Klinische Pharmakologie; 20151001-20151002; Köln; DOC15vklipha18 /20150924/

مصطلحات موضوعية: ddc: 610

Relation: http://dx.doi.org/10.3205/15vklipha18; http://nbn-resolving.de/urn:nbn:de:0183-15vklipha182; http://www.egms.de/en/meetings/vklipha2015/15vklipha18.shtml

الاتاحة: https://doi.org/10.3205/15vklipha18
http://nbn-resolving.de/urn:nbn:de:0183-15vklipha182
http://www.egms.de/en/meetings/vklipha2015/15vklipha18.shtml

المؤلفون: Hong, H, Fuhr, U, Gründemann, D

المصدر: 17. Jahreskongress für Klinische Pharmakologie; 20151001-20151002; Köln; DOC15vklipha21 /20150924/

مصطلحات موضوعية: ddc: 610

Relation: Bach M, Grigat S, Pawlik B, Fork C, Utermöhlen O, Pal S, Banczyk D, Lazar A, Schömig E, Gründemann D. Fast set-up of doxycycline-inducible protein expression in human cell lines with a single plasmid based on Epstein-Barr virus replication and the simple tetracycline repressor. FEBS J. 2007 Feb;274(3):783-90.; Masuda S, Terada T, Yonezawa A, Tanihara Y, Kishimoto K, Katsura T, Ogawa O, Inui K. Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2. J Am Soc Nephrol. 2006 Aug;17(8):2127-35.; http://dx.doi.org/10.3205/15vklipha21; http://nbn-resolving.de/urn:nbn:de:0183-15vklipha216; http://www.egms.de/en/meetings/vklipha2015/15vklipha21.shtml

الاتاحة: https://doi.org/10.3205/15vklipha21
http://nbn-resolving.de/urn:nbn:de:0183-15vklipha216
http://www.egms.de/en/meetings/vklipha2015/15vklipha21.shtml

المؤلفون: Suleiman, AA, Frechen, S, Scheffler, M, Nogova, L, Wolf, J, Fuhr, U

المصدر: 16. Jahreskongress für Klinische Pharmakologie; 20141009-20141010; Köln; DOC14vklipha26 /20140925/

مصطلحات موضوعية: ddc: 610

Relation: Chmielecki J, et al. Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling. Sci Transl Med. 2011;3(90):90ra59.; Foo J, et al. Effects of pharmacokinetic processes and varied dosing schedules on the dynamics of acquired resistance to erlotinib in EGFR-mutant lung cancer. J Thorac Oncol. 2012;7(10):1583-93.; Lee SM, et al. First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2012;13(11):1161-70.; Zander T, et al. Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18)F]fluorodeoxyglucose and [(18)F]fluorothymidine positron emission tomography. J Clin Oncol. 2011;29:1701-8.; http://dx.doi.org/10.3205/14vklipha26; http://nbn-resolving.de/urn:nbn:de:0183-14vklipha266; http://www.egms.de/en/meetings/vklipha2014/14vklipha26.shtml

الاتاحة: https://doi.org/10.3205/14vklipha26
http://nbn-resolving.de/urn:nbn:de:0183-14vklipha266
http://www.egms.de/en/meetings/vklipha2014/14vklipha26.shtml

المؤلفون: Sigaroudi, A, Stelzer, C, Braun, T, Schröter, M, Kinzig, M, Fuhr, U, Holzgrabe, U, Sörgel, F

المصدر: 16. Jahreskongress für Klinische Pharmakologie; 20141009-20141010; Köln; DOC14vklipha14 /20140925/

مصطلحات موضوعية: ddc: 610

Relation: http://dx.doi.org/10.3205/14vklipha14; http://nbn-resolving.de/urn:nbn:de:0183-14vklipha147; http://www.egms.de/en/meetings/vklipha2014/14vklipha14.shtml

الاتاحة: https://doi.org/10.3205/14vklipha14
http://nbn-resolving.de/urn:nbn:de:0183-14vklipha147
http://www.egms.de/en/meetings/vklipha2014/14vklipha14.shtml

المؤلفون: Dahlinger, D, Frechen, S, Nücken, D, Fuhr, U

المصدر: 16. Jahreskongress für Klinische Pharmakologie; 20141009-20141010; Köln; DOC14vklipha25 /20140925/

مصطلحات موضوعية: ddc: 610

Relation: Die überaktive Blase (ÜAB). AWMF Register Nr. 015/007. Klasse: S2k. Stand Juni 2010. Available from: http://www.awmf.org/uploads/tx_szleitlinien/015-007l_S2k_Ueberaktive_Blase_Add_2014-07.pdf [accessed August 2014]; Cheng Y, Prusoff WH. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973 Dec 1;22(23):3099-108.; Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001 Jun;87(9):760-6. DOI:10.1046/j.1464-410x.2001.02228.x; Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003 May;20(6):327-36.; http://dx.doi.org/10.3205/14vklipha25; http://nbn-resolving.de/urn:nbn:de:0183-14vklipha257; http://www.egms.de/en/meetings/vklipha2014/14vklipha25.shtml

الاتاحة: https://doi.org/10.3205/14vklipha25
http://nbn-resolving.de/urn:nbn:de:0183-14vklipha257
http://www.egms.de/en/meetings/vklipha2014/14vklipha25.shtml

المؤلفون: Scheidl, E, Benz, C, Loeff, P, Groneck, V, König, A, Schulte-Fischedick, A, Lück, H, Fuhr, U

المصدر: 16. Jahreskongress für Klinische Pharmakologie; 20141009-20141010; Köln; DOC14vklipha36 /20140925/

مصطلحات موضوعية: ddc: 610

Relation: http://dx.doi.org/10.3205/14vklipha36; http://nbn-resolving.de/urn:nbn:de:0183-14vklipha362; http://www.egms.de/en/meetings/vklipha2014/14vklipha36.shtml

الاتاحة: https://doi.org/10.3205/14vklipha36
http://nbn-resolving.de/urn:nbn:de:0183-14vklipha362
http://www.egms.de/en/meetings/vklipha2014/14vklipha36.shtml

المؤلفون: Mc Laughlin, A., Schmulenson, E., Teplytska, O., Zimmermann, S., Opitz, P., Groenland, S. L., Huitema, A., Steeghs, N., Mueller, L., Fuxius, S., Joerger, M., Mayer, F., Fuhr, U., Holdenrieder, S., Hempel, G., Scherf-Clavel, O., Mikus, G., Jaehde, U., Kloft, C.

المساهمون: Institut für Laboratoriumsmedizin (keine SAP-Zuordnung!)

مصطلحات موضوعية: info:eu-repo/classification/ddc

Relation: https://mediatum.ub.tum.de/1657892

الاتاحة: https://mediatum.ub.tum.de/1657892

المؤلفون: Nogova, L., Mattonet, C., Scheffler, M., Michels, S., Bos, M., Heukamp, L.C., Schildhaus, H., Fuhr, U., Eberhardt, W.E., Reis, H., Wiesweg, M., Schmid, K.W., Schoch, G., Serke, M., Ko, Y., Schuler, M., Büttner, R., Wolf, J.

المصدر: Annals of Oncology ; volume 25, page iv433 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1093/annonc/mdu349.17
https://api.elsevier.com/content/article/PII:S092375341952659X?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S092375341952659X?httpAccept=text/plain
http://academic.oup.com/annonc/article-pdf/25/suppl_4/iv433/9691575/mdu349.17.pdf

المؤلفون: Breuer, C., Wachall, B., Gerbeth, K., Abdel-Tawab, M., Fuhr, U.

المصدر: European Journal of Clinical Pharmacology ; volume 69, issue 6, page 1303-1310 ; ISSN 0031-6970 1432-1041

الاتاحة: http://dx.doi.org/10.1007/s00228-012-1465-5
http://link.springer.com/article/10.1007/s00228-012-1465-5/fulltext.html
http://link.springer.com/content/pdf/10.1007/s00228-012-1465-5.pdf
http://link.springer.com/content/pdf/10.1007/s00228-012-1465-5

المؤلفون: Zadoyan, G., Rokitta, D., Klement, S., Dienel, A., Hoerr, R., Gramatté, T., Fuhr, U.

المصدر: European Journal of Clinical Pharmacology ; volume 68, issue 5, page 553-560 ; ISSN 0031-6970 1432-1041

الاتاحة: http://dx.doi.org/10.1007/s00228-011-1174-5
http://www.springerlink.com/index/pdf/10.1007/s00228-011-1174-5

المؤلفون: Jetter, A, Fätkenheuer, G, Frank, D, Klaassen, T, Seeringer, A, Doroshyenko, O, Kirchheiner, J, Hein, W, Schömig, E, Fuhr, U, Wyen, C

المصدر: Jetter, A; Fätkenheuer, G; Frank, D; Klaassen, T; Seeringer, A; Doroshyenko, O; Kirchheiner, J; Hein, W; Schömig, E; Fuhr, U; Wyen, C (2010). Do activities of cytochrome P450 (CYP)3A, CYP2D6 and P-glycoprotein differ between healthy volunteers and HIV-infected patients? Antiviral Therapy, 15(7):975-983.

مصطلحات موضوعية: Clinic for Clinical Pharmacology and Toxicology, 610 Medicine & health

وصف الملف: application/pdf

Relation: https://www.zora.uzh.ch/id/eprint/38657/15/Jetter-AVT-KAL-VOL-ZORA-2V.pdf; info:pmid/21041912; urn:issn:1359-6535

الاتاحة: https://www.zora.uzh.ch/id/eprint/38657/
https://doi.org/10.3851/IMP1648

المؤلفون: Abduljalil, K, Frank, D, Gaedigk, A, Klaassen, T, Tomalik-Scharte, D, Jetter, A, Jaehde, U, Kirchheiner, J, Fuhr, U

المصدر: Abduljalil, K; Frank, D; Gaedigk, A; Klaassen, T; Tomalik-Scharte, D; Jetter, A; Jaehde, U; Kirchheiner, J; Fuhr, U (2010). Assessment of activity levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 genes by population pharmacokinetics of dextromethorphan. Clinical Pharmacology and Therapeutics, 88(5):643-651.

مصطلحات موضوعية: Clinic for Clinical Pharmacology and Toxicology, 610 Medicine & health

وصف الملف: application/pdf

Relation: https://www.zora.uzh.ch/id/eprint/38656/1/PopPK_Dextromethorphan_26052010.pdf; info:pmid/20881950; urn:issn:0009-9236

الاتاحة: https://www.zora.uzh.ch/id/eprint/38656/
https://www.zora.uzh.ch/id/eprint/38656/1/PopPK_Dextromethorphan_26052010.pdf
https://doi.org/10.1038/clpt.2010.137

المؤلفون: Gascon, P., Fuhr, U., Sörgel, F., Kinzig-Schippers, M., Makhson, A., Balser, S., Einmahl, S., Muenzberg, M.

مصطلحات موضوعية: clinical trials

وصف الملف: text/html

Relation: http://annonc.oxfordjournals.org/cgi/content/short/21/7/1419; http://dx.doi.org/10.1093/annonc/mdp574

الاتاحة: http://annonc.oxfordjournals.org/cgi/content/short/21/7/1419
https://doi.org/10.1093/annonc/mdp574

المؤلفون: Kohl, V., Müller, C., Cornely, O. A., Abduljalil, K., Fuhr, U., Vehreschild, J. J., Scheid, C., Hallek, M., Rüping, M. J. G. T.

المصدر: Antimicrobial Agents and Chemotherapy ; volume 54, issue 1, page 207-212 ; ISSN 0066-4804 1098-6596

الاتاحة: http://dx.doi.org/10.1128/aac.01027-09
https://journals.asm.org/doi/pdf/10.1128/AAC.01027-09

المؤلفون: Muschler, E, Lal, J, Jetter, A, Rattay, A, Zanger, U, Zadoyan, G, Fuhr, U, Kirchheiner, J

المصدر: Muschler, E; Lal, J; Jetter, A; Rattay, A; Zanger, U; Zadoyan, G; Fuhr, U; Kirchheiner, J (2009). The role of human CYP2C8 and CYP2C9 variants in pioglitazone metabolism in vitro. Basic & Clinical Pharmacology & Toxicology, 105(6):374-379.

مصطلحات موضوعية: Clinic for Clinical Pharmacology and Toxicology, 610 Medicine & health

وصف الملف: application/pdf

Relation: https://www.zora.uzh.ch/id/eprint/25549/10/Muschler.pdf; info:pmid/19614891; urn:issn:1742-7835

الاتاحة: https://www.zora.uzh.ch/id/eprint/25549/
https://www.zora.uzh.ch/id/eprint/25549/10/Muschler.pdf